FIGURE 1. The dotted line represents the relation between plasma concentration (P) and the urine excretion rate (UV) of a substance neither reabsorbed nor excreted by the renal tubules when the plasma concentration is increased by infusion. The continuous line represents the relationship during the infusion of phosphate in a subject with the same glomerular filtration rate (GFR). The tubular maximum reabsorptive capacity (TmP) is the distance A on the y axis between the dotted line and the linear portion of the continuous curve. Since the slope of the line (UV/P) is GFR, TmP/GFR is the intercept of the linear part of the curve with the x axis. (Reproduced from Reference 7 by permission of Butterworth-Heinemann Ltd and the editors.)
linear relationship between the increase of plasma phosphate and the rate of phosphate excretion. TmP/GFR is the intercept of the linear part of the curve with the plasma concentration axis.
Bijvoet's infusion technique is clearly impracticable for routine use. However, Bijvoet, Morgan and Fourman/ were able to use the relationships in the infusion data between plasma phosphate concentration, the phosphate/creatinine clearance ratio and TmP/GFR to predict TmP/GFR from fasting urine and MEASUREMENT OF TmP/GFR Bijvoet! measured the renal handling of phosphate in normal subjects and patients with parathyroid and thyroid disorders by carrying out phosphate infusions. The continuous line in Fig. I shows how phosphate appears in the urine at a gradually increasing rate as plasma phosphate is increased, and that there is no clear-cut phosphate threshold. When all nephrons are reabsorbing maximally there is a Correspondence: Dr R B Payne, E-mail: rbp(a,rugosa.demon. co.uk This article was prepared at the invitation of the Clinical Laboratory Investigations Standing Committee of the Association of Clinical Biochemists. The views expressed are those of the author. Olaf Bijvoet I devised the ratio of the renal tubular maximum reabsorption rate of phosphate to glomerular filtration rate (TmP/GFR) to help to distinguish hypercalcaemia due to hyperparathyroidism from other causes of hypercalcaemia. Although it has been superseded for this purpose by the measurement of plasma intact parathyroid hormone (PTH), it is still clinically useful. TmP/GFR measures maximum renal tubular phosphate reabsorption in mass per unit volume of glomerular filtrate. It is independent of the two other factors that affect plasma phosphate concentration: the rate of phosphate flow into the extracellular space from gut, cells and bone, and the glomerular filtration rate. TmP/GFR has replaced earlier indices of renal phosphate handling such as the phosphate excretion index (PEl) and the index of phosphate excretion (IPE) because it alone has a physiological basis.?
Disorders of plasma phosphate and indications for its measurement have been reviewed recently.' The present paper describes the measurement of TmP/GFR and its role in diagnosis and monitoring.
Additional key phrases: phosphate depletion; neonatal osteomalacia, oncogenic osteomalcia Payne plasma concentrations without the need for infusions. Although nomograms derived from Bijvoet's infusion data have been devised for the calculation of TmP/GFR,2.4 it is more convenient to use the algorithm of Kenny and Glens which can be incorporated into a laboratory computer so that the calculation is carried out automatically.
To perform the test the patient is fasted, overnight if possible. The overnight urine is discarded. The next untimed urine is collected and a blood specimen taken. Urine and plasma phosphate concentrations (Up and Pp) and urine and plasma creatinine concentrations (U cr and Per) are measured. Samples are taken in a fasting steady state because there are circadian changes in plasma and urine phosphates and because plasma and urine creatinine may change postprandially.?
The ratio of phosphate clearance to creatinine clearance gives the fraction of filtered phosphate that appears in the urine, the fractional excretion of phosphate, for example 0·15 or 15%. This fraction subtracted from 1·0 then gives the fractional tubular reabsorption of phosphate (TRP), in the example 0·85. TRP is calculated by entering the fasting urine and plasma concentrations, in the same concentration units, into the fol1owing equation:
If TRP is less than or equal to 0·86 then the patient's values lie on the linear part of a curve similar to the continuous line in Fig. I and phosphate reabsorption is at its maximum. Assuming that the plasma phosphate concentration is equal to the concentration in glomerular filtrate, TRP multiplied by plasma phosphate gives the maximum reabsorption per unit volume of glomerular filtrate. Thus,
However, if TRP is greater than 0·86 the patient's values lie on the non-linear 'splay' part of a curve similar to the continuous line in Fig. I and reabsorption is not at its maximum. Fortunately, the shape of the 'splay' is the same in al1 patients.I and Kenny and Glen' were able to define it mathematically by fitting a rectangular hyperbola so that maximum reabsorption per unit volume of glomerular filtrate can be predicted:
then TmP/GFR=exxP p If plasma phosphate is measured in mrnol/L, then TmP/GFR is expressed in mmol/L of glomerular filtrate. The assumptions of the calculation are that the plasma phosphate concentration is equal to its concentration in glomerular filtrate and that creatinine clearance is a close approximation to GFR. However, these assumptions also apply to the reference data. No formal studies of repeatability seem to have been reported.
REFERENCE RANGES
The adult 95% reference range is about 0·80--1·35 mmol/L, Some age-related ranges are shown in Table I . There are high values in neonates and infants" which become somewhat lower during childhood, but show no trend with age and no sex difference." After puberty there is a paral1el decrease in TmP/GFR, hydroxyproline excretion and plasma alkaline phosphatase to adult values, with a significant association between TmP/GFR and these indices of bone turnover. 10 Values in both men and women show a slight decline with age, although the upper limit for men remains constant." TmP/GFR = ratio of tubular maximum reabsorption rate of phosphate to glomerular filtration rate.
TmP/GFR IN DISEASE
Phosphate flow TmP/GFR decreases when plasma phosphate is increased by an increase in the rate of phosphate flow into the extracellular space from gut, cells or bone, and increases when flow is decreased. These observations suggest that the rate of phosphate reabsorption is under the control of a phosphaturic hormone that exhibits typical homeostatic feedback control. The evidence for the existence of such a hormone is discussed below. TmP/GFR is decreased in hyperphosphataemia due to increased phosphate flow from the gut in vitamin D overdose and in sarcoidosis (because of enhanced (-0( hydroxylation of 25hydroxycholecalciferol) and due to increased flow from cells in rhabdomyolysis, transfusion haemolysis and the tumour lysis syndrome. TmP/GFR is increased in hypophosphataemia due to decreased phosphate flow in neonatal rickets following placental insufficiency, in dietary deprivation in anorexia nervosa and bulimia, in excessive administration of phosphate-binding antacids, in the 'hungry bone' syndrome and during rapid neoplastic proliferation. Measurement of TmP/GFR plays little part in the diagnosis and management of these conditions.
Phosphate redistribution
Hypophosphataemia may occur as the consequence of a shift into cells during glucose infusion or during refeeding after dietary deprivation. Although such shifts result in a decreased phosphate flow, TmP/GFR is found to be decreased if measured in the non-fasting state,12.13 probably due to direct hormonal effects on tubular reabsorption of increased insulin and decreased growth hormone concentrations. Thus, refeeding may result in significant renal phosphate loss even though the steady state (fasting) TmP/GFR is initially normal. The shift into cells that may occur in respiratory alkalosis is also accompanied by a reduced TmP/ GFR due to a direct renal effect. If such renal losses persist they may result in severe phosphate depletion, intracellular ATP depletion, impaired renal tubular function and a reduced steadystate TmP/GFR, thus exacerbating the depletion. The measurement of TmP/GFR may therefore be useful in hypophosphataemia even when it is thought to be due to redistribution because a low value indicates the need for phosphate replacement."
Hormonal effects on tubular reabsorption While the main role of PTH is calcium homeostasis, it is also an important determinant of phosphate reabsorption. In hypoparathyroidism, whether primary, postoperative or secondary to hypercalcaemia, TmP/GFR increases and in hyperparathyroidism it decreases. Growth hormone has the opposite effect on reabsorption, so that TmP/GFR and plasma phosphate are commonly raised in acromegaly. (A possible future role of TmP/GFR is in the selection of normal variant short children for long-term growth hormone treatment. There is some evidence that those who show the largest increase of TmP/GFR during short-term growth hormone administration will respond best to long-term therapy. IS) The earlier use of TmP/GFR in the assessment of hypercalcaemia was inefficient because some malignant tumours secrete PTH-related peptide (PTHrP) which has the same effect as PTH on renal phosphate handling." Now that intact PTH assays are available TmP/GFR plays no part in the diagnosis of disorders of calcium homeostasis.
Oncogenic, or tumour-induced, osteomalacia is a rare syndrome characterized by osteomalacia, reduced TmP/GFR and hypophosphataemia together with low plasma concentrations of 1,25-dihydroxycholecalciferol D (I,25-DHCq associated with a tumour which is often mesenchymal and benign, but may be malignant.!":" All the features of the syndrome disappear following successful tumour removal, and they can be reproduced in experimental animals by infusion of saline tumour extracts or by tumour transplantation. The humoral factor produced by the tumour which decreases TmP/ GFR and inhibits 1,25-DHCC synthesis (or facilitates its catabolism) may be the putative hormone responsible for phosphate homeostasis or be structurally related to it by analogy with PTH and PTHrP. Measurement of TmP/GFR and 1,25-DHCC are essential to confirm the provisional diagnosis, to prompt the search for an occult tumour and to monitor the response to surgery.
X-linked hypophosphataemic rickets (vitamin D resistant rickets) is characterized by the same biochemical abnormalities as oncogenic osteomalacia-reduced TmP/GFR and low plasma concentrations of 1,25-DHCC.19 Plasma albumin-adjusted calcium and PTH are usually normal, and alkaline phosphatase is elevated. It seems likely that the condition is due to The syndrome can also be acquired as a result of exposure to drugs, particularly chemotherapeutic agents, and toxins such as heavy metals, toluene and paraquat. It can result from heavy Bence Jones proteinuria and from antitubular basement membrane antibodies in acute nephritis. All the acquired causes are potentially reversible. Because the renal damage may cause nephron loss and a reduction in GFR, TmP/ GFR is a better measure than plasma phosphate concentration alone for the quantitative monitoring of the recovery of tubular function.
Depletion of the intracellular ions magnesium, potassium and phosphate can also result in disordered tubular function with features of the Fanconi syndrome. In severe phosphate depletion TmP/GFR can be very low whatever the primary cause.!" Van Dissell and colleagues-" reported a patient admitted with malnutrition due to anorexia nervosa who developed severe hypophosphataemia during enteral tube feeding with a standard protein, fat and carbohydrate preparation even though it contained 38'4 mrnol/L of potassium and 16mmoljL of phosphate (Fig. 2) . TmPjGFR was found to be extremely low and nearly all the administered phosphate was recovered in the urine. It is likely that an initial dietary phosphate deficiency was exacerbated by the insulin and growth hormone response to refeeding, causing a reduced TmPj GFR and marked intracellular phosphate depletion (erythrocyte ATP and 2,3-DPG were shown to be low). Intravenous potassium phosphate together with a marked reduction in calorie Disordered tubular function Hereditary hypophosphataemic rickets with hypercalciuria is a rare condition characterized by a low TmP/GFR and hypophosphataemia but, in contrast to X-linked hypophosphataemic rickets, there is a high plasma 1,25-DHCC concentration resulting in increased calcium absorption, low or low normal PTH concentrations and hypercalciuria.'? It appears to be due to a primary defect in tubular phosphate reabsorption with secondary stimulation of 1,25-DHCC synthesis. Some family members who do not have rickets have milder hypophosphataemia due to a lesser reduction in TmP/GFR, but also have elevation of 1,25-DHCC with hypercalciuria and may present with renal stones.
The idea that a mild reduction in TmP/GFR is the basis of all hypercalciuric nephrolithiasis, including so-called absorptive hypercalciuria," 5 is still controversial. 26 It will be difficult to prove because a reduced TmP/GFR, sometimes with glycosuria and tubular proteinuria, is common in patients with any kind of renal stone, presumably as a result of direct tubular damage. 27 ,2x The merit of measuring TmP/GFR in patients with hypercalciuria and nephrolithiasis remains to be demonstrated.
The renal Fanconi syndrome is characterized biochemically by a generalized disturbance of proximal tubular reabsorption involving amino acids, glucose, bicarbonate, citrate and urate as well as phosphate, together with impaired synthesis of 1,25-DHCC. The syndrome can be inherited directly or can be the result of an inborn error producing a metabolite which causes tubular damage. In some of these inborn errors, including galactosaernia, hereditary fruc-overproduction of the putative phosphaturic hormone. An analogous syndrome in the mouse, caused by a mutation at the Hyp locus on the X chromosome, is not corrected by renal transplantation.P adding weight to the hormonal theory. Measurements of TmP/GFR and 1,25-DHCC help to confirm the diagnosis even at an early presymptomatic age, and clearly distinguish the condition from the late development of rickets from intrauterine phosphate depletion in which TmP/GFR and 1,25-DHCC are high normal or raised. There is recent evidence that growth hormone administration can partially correct the abnormalities of TmP/GFR and 1,25-DHCC in X-linked hypophosphataemic rickets. 2 
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Ann Clin Biochem 199R: 35 intake resulted in a gradual increase of both TmP/GFR and plasma phosphate. TmP/GFR rose above normal, presumably because phosphate flow was decreased by cell uptake, and it did not return to the normal range until day 36. The return of TmP/GFR to normal thus provided a valuable indication that intracellular phosphate repletion was complete.
CONCLUSIONS
TmP/GFR is no longer used in the investigation of disturbances of calcium homeostasis. It seems unlikely that it will prove of value in the assessment of renal stone disease.
The conditions that cause phosphate redistribution also increase renal phosphate loss, so if hypophosphataemia persists a low (fasting) TmP/GFR indicates the need for phosphate replacement. In the treatment of severe phosphate deficiency, TmP/GFR can be used as an indicator of intracellular repletion. The test is also useful for monitoring the renal tubular response to therapy in tubular damage due to metabolites, drugs or toxins.
The measurement of TmP/GFR (together with plasma 1,25-DHCC) is required for the diagnosis of X-linked hypophosphataernic rickets and hereditary hypophosphataemic rickets with hypercalciuria, and to monitor the response to growth hormone therapy in the former condition. Its value in the selection of short children who will respond to growth hormone treatment remains to be confirmed. Measurements of both TmP/G FR and plasma 1,25-DHCC are central to the diagnosis of oncogenic osteomalacia.
